January 20, 2020 – Michael Argyres, MD, is Flagship’s Director of Pathology, diagnostic biomarkers. Mike received his BA at UC Berkeley in molecular biology, his MD at the Medical College of Wisconsin, did his pathology residency at the University of Colorado, a surgical pathology fellowship at Stanford University, and completed an Advanced Practical Program in Prostate Pathology offered by the College of American Pathologists.
Here’s more from Mike.
“I was always interested in biology and was dissecting frogs before I started kindergarten. I enjoyed molecular biology research but wanted to have a more direct impact on people’s lives, so I went to medical school.
Before joining Flagship, I was a hospital-based anatomic and clinical pathologist for 20 years in community and academic practice. Prior to that, I did molecular biology research on rous sarcoma virus at UC Berkeley, and Apolipoprotein B research at the Gladstone Foundation in San Francisco.
At Flagship, I am passionate about furthering the tools that pathologists use to determine prognosis and prediction of response to therapy for cancer patients. I am also thrilled to be actively working on clinical trials in gene therapy, a dream of mine since learning about the Philadelphia chromosome my first year in college (1985!)
Looking toward the future, I believe that computational pathology will revolutionize the field of pathology by bringing quantitative analytics to a field long relegated to subjective, verbal interpretations.
My advice for aspiring scientists, doctors, and researchers is that there are endless possibilities. Dream big, become part of a great team like the one at Flagship, and enjoy your time here on earth. You only get one life to live, so make it worthwhile.”